Scientific Committees at the ESMO Congress 2024

The ESMO Congress is a globally influential oncology platform that brings together clinicians, researchers, patient advocates, journalists, and healthcare industry representatives from around the world.

ESMO24 will showcase the latest cutting-edge data, offer high-quality education, and provide excellent networking opportunities for oncologists and other stakeholders worldwide.

The innovative LIVE Plus Congress format will allow participants to attend either in person in Barcelona or online via the Virtual Congress Platform from 13-17 September 2024.

Here are the Scientific Committees at the ESMO24 C0ngress:

Basic science & translational research (TR)

• Track Chair: Philippe Bedard Toronto, ON, Canada

• Chiara Ambrogio, Turin, Italy
• Federica Di Nicolantonio, Turin, Italy
• Moritz Gerstung Heidelberg, Germany
• Göran Jönsson, Lund, Sweden
• Sherene Loi, Melbourne, VIC, Australia
• Noel De Miranda, Leiden, Netherlands
• Caetano Reis e Sousa, London, UK
• Daniela Robles-Espinoza, Mexico City, Mexico
• Daniela Thommen, Amsterdam, Netherlands
• Naureen Starling, London, UK
• Ana Vivancos, Barcelona, Spain
• Marc Vooijs, Maastricht, Netherlands

Breast cancer, early stage

• Track Chair: Ann Partridge, Boston, MA, USA

• François-Clement Bidard, Paris , France
• Charlotte Coles, Cambridge, UK
• Nadia Harbeck, Munich, Germany
• Stephen Johnston, London, UK
• Kevin Kalinsky, Atlanta, GA, USA
• Marleen Kok, Amsterdam, Netherlands
• Ava Kwong, Hong Kong, China
• Elgene Lim, Darlinghurst, NSW, Australia
• Shani Paluch-Shimon, Jerusalem, Israel
• Kalliopi Siziopikou  , Chicago, IL, USA
• Petra Tesarova, Prague, Czech Republic

Breast cancer, metastatic

• Track Chair: Christos Sotiriou, Brussels, Belgium

• Aditya Bardia, Boston, MA, USA
• Giampaolo Bianchini, Milan, Italy
• Giuseppe Curigliano, Milan, Italy
• Lucia Del Mastro, Genoa, Italy
• Karen Gelmon, Vancouver, BC, Canada
• Seock-Ah Im, Seoul, Republic of Korea
• Barbara Pistilli, Villejuif, France
• Cristina Saura, Barcelona, Spain
• Tira Tan , Singapore,
• Christoph Thomssen, Halle, Germany
• Andrew Tutt, London, UK
• Sandra Ximena Franco, Bogota, Colombia

CNS

• Track Chair: Monika Hegi, Lausanne, Switzerland

• Anna Sophie Berghoff, Vienna, Austria
• Sebastian Brandner, London, UK
• Dieta Brandsma, Amsterdam, Netherlands
• Amélie Darlix, Montpellier, France
• Frank Giordano, Mannheim, Germany
• Giuseppe Lombardi, Padua, Italy
• Sabine Mueller , San Francisco, CA, Switzerland
• Evangelia Razis, Athens, Greece
• Nader Sanai, Phoenix, AZ, USA
• Roger Stupp, Chicago, IL, USA
• Emeline Tabouret, Marseille, France
• Frank Winkler, Heidelberg, Germany

Developmental therapeutics

• Track Chair: Elena Garralda, Barcelona, Spain

• Alex Adjei, Sandusky, OH, USA
• Udai Banerji, London, UK
• Alex Drilon, New York, NY, USA
• Fernanda Herrera, Lausanne, Switzerland
• Sophie Postel-Vinay, Villejuif, France
• Thanyanan Reungwetwattana Baisamut, Bangkok, Thailand
• Lillian Siu, Toronto, ON, Canada
• Anastasios Stathis, Bellinzona, Switzerland
• Neeltje Steeghs , Amsterdam, Netherlands
• Daniel Tan, Singapore,
• Ignacio Wistuba, Houston, TX, USA

Gastrointestinal tumours, upper digestive

• Track Chair: Sarah Derks, Amsterdam, Netherlands

• Tania Fleitas, Valencia, Spain
• Yelena Janjigian, New York, NY, USA
• Angela Lamarca, Madrid, Spain
• Rupert Langer, Linz, Austria
• Trevor Leong, Melbourne, VIC, Australia
• Sylvie Lorenzen, Munich, Germany
• Shiraz Markar, Oxford , UK
• Davide Melisi, Verona, Italy
• Magnus Nilsson, Solna, Sweden
• Radka Obermannová, Brno, Czech Republic
• Filippo Pietrantonio, Milan, Italy
• Arndt Vogel, Hannover, Germany

Gastrointestinal tumours, lower digestive

• Track Chair: Jenny Seligmann, Leeds, UK

• Eva Angenete, Goteborg, Sweden
• Guillem Argiles Martinez, New York, NY, USA
• Dirk Arnold, Hamburg, Germany
• Myriam Chalabi, Amsterdam, Netherlands
• Su Pin Choo, Singapore,
• Rodrigo Dienstmann, Sao Paulo , Brazil
• Michel Ducreux, Villejuif, France
• Elena Elez, Barcelona, Spain
• Maria Antonietta Gambacorta, Rome, Italy
• Sara Lonardi, Padua , Italy
• Dominik Modest, Berlin, Germany
• Noelia Tarazona Llavero, Valencia, Spain

Genitourinary tumours, prostate

• Track Chair: Arun Azad, Melbourne, VIC, Australia

• Neeraj Agarwal, Salt Lake City, UT, USA
• Gerhardt Attard, London, UK
• Himisha Beltran, Boston, MA, USA
• Pierre Blanchard, Villejuif, France
• Elena Castro, Madrid, Spain
• Karim Fizazi, Villejuif, France
• Ken  Herrmann, Essen, Germany
• Niven Mehra, Nijmegen, Netherlands
• Dana Rathkopf, New York, NY, USA
• Derya Tilki, Hamburg, Germany
• Ursula Vogl, Bellinzona, Switzerland

Genitourinary tumours, non-prostate

• Track Chair: Petros Grivas, Seattle, WA, USA

• Leslie Ballas , Los Angeles, CA, USA
• Aristotelis Bamias, Athens, Greece
• Eva Comperat, Vienna, Austria
• Maria De Santis, Berlin, Germany
• Ignacio Duran, Santander, Spain
• Silke Gillessen, Bellinzona, Switzerland
• Ashish Kamat , Houston, TX, USA
• Andrea Necchi, Milan, Italy
• Camillo Porta, Bari, Italy
• Thomas Powles, London, UK
• Srikala Sridhar, Toronto, ON, Canada
• Michiel van der Heijden, Amsterdam, Netherlands

Gynaecological cancers

• Track Chair: Charlie Gourley, Edinburgh, UK

• Susana Banerjee, London, UK
• Jack Junjie Chan, Singapore,
• Nicoletta Colombo, Milan, Italy
• Carien Creutzberg, Leiden, Netherlands
• Florence Joly, Caen, France
• Vicky Makker, New York, NY, USA
• Frederik Marmé, Mannheim, Germany
• Xavier Matias-Guiu, Hospitalet de Llobregat, Spain
• Linda Mileshkin, Melbourne, VIC, Australia
• Ana Oaknin, Barcelona, Spain
• Isabelle Ray-Coquard, Lyon, France

Haematological malignancies

• Track Chair: Marco Ladetto, Alessandria, Italy

• Silvia Bea, Barcelona, Spain
• Christian Buske, Ulm, Germany
• Olivier Casanovas, Dijon, France
• Martin Dreyling, Munich, Germany
• Maria Gomes da Silva, Lisbon, Portugal
• Won Seog Kim, Seoul, Republic of Korea
• Ana Marin-Niebla, Barcelona, Spain
• Carlo Visco, Verona, Italy
• Elena Zamagni, Bologna, Italy
• Thorsten Zenz, Zurich, Switzerland

Head and neck cancer, excl. thyroid

• Track Chair: Sjoukje Oosting, Groningen, Netherlands

• Irene Brana, Barcelona, Spain
• Kevin Harrington, London, UK
• Keith Hunter, Liverpool, UK
• Brigette Ma, Hong Kong, China
• Jean-Pascal Machiels, Brussels, Belgium
• Hisham Mehanna, Birmingham, UK
• Ester Orlandi, Pavia, Italy
• Amanda Psyrri, Athens, Greece
• Anna Spreafico, Toronto, ON, Canada
• Petr  Szturz, Lausanne, Switzerland
• Makoto Tahara, Kashiwa, Japan
• Ingeborg Tinhofer, Berlin, Germany

Investigational immunotherapy

• Track Chair: Fiona Thistlethwaite, Manchester, UK

• Paolo Ascierto, Naples, Italy
• Victoria Atkinson, Brisbane, Qld, Australia
• Emiliano Calvo, Madrid, Spain
• Stephane Champiat, Villejuif, France
• Tanja De Gruijl, Amsterdam, Netherlands
• John Haanen, Amsterdam, Netherlands
• Toh Han Chong , Singapore,
• Lana Kandalaft, Lausanne, Switzerland
• Ulrike Kohl, Leipzig, Germany
• Ignacio Melero, Pamplona, Spain
• Antoni Ribas, Los Angeles, CA, USA
• Samra Turajlic, London, UK

Melanoma and other skin tumours

• Track Chair: Karijn Suijkerbuijk, Utrecht , Netherlands

• Boris Bastian, San Francisco, CA, USA
• Christian Blank, Amsterdam, Netherlands
• Helen Gogas, Athens, Greece
• Jessica Hassel, Heidelberg, Germany
• Mathilde Jalving, Groningen, Netherlands
• Ivan  Marquez-Rodas, Madrid , Spain
• Bart Neyns, Brussels, Belgium
• Caroline Robert , Villejuif, France
• Inge Marie Svane, Herlev, Denmark
• Hussein Tawbi, Houston, TX, USA
• Teresa Troiani, Naples, Italy
• Alexander Van Akkooi, Wollstonecraft, NSW, Australia

NETs and endocrine tumours

• Track Chair: Chris Verslype, Leuven, Belgium

• Ivan  Borbath, Brussels, Belgium
• Jaume  Capdevila, Barcelona, Spain
• Andreas Kjaer, Copenhagen, Denmark
• Sara De Dosso, Bellinzona, Switzerland
• Marco Volante, Turin, Italy
• Nicola  Fazio, Milan, Italy
• Rocio García Carbonero, Madrid, Spain
• Els Nieveen van Dijkum, Amsterdam, Netherlands
• Staffan Welin, Uppsala, Sweden
• Rachel  Riechelmann, Sao Paulo , Brazil
• Eva Segelov, Bern, Switzerland
• Annemiek  Walenkamp, Groningen, Netherlands

Non-metastatic NSCLC and other thoracic malignancies

• Track Chair: Jarushka Naidoo, Dublin, Ireland

• Alfredo Addeo, Geneva, Switzerland
• Lauren Byers, Houston, TX, USA
• Antonio Calles, Madrid, Spain
• Tanja Cufer, Ljubljana, Slovenia
• Rafal Dziadziuszko, Gdansk, Poland
• Pilar Garrido, Madrid, Spain
• Silvia Novello, Turin, Italy
• Isabelle Opitz, Zurich, Switzerland
• Kersti Oselin, Tallin, Estonia
• Teodora Radonic, Amsterdam, Netherlands
• Jordi Remon, Villejuif, France
• Heather Wakelee, Stanford, CA, USA

NSCLC, metastatic

• Track Chair: Benjamin Besse , Villejuif, France

• Mark Awad, Boston, MA, USA
• Fiona Blackhall, Manchester, UK
• Anne-Marie Dingemans, Rotterdam, Netherlands
• Roberto Ferrara, Milan, Italy
• Marina Garassino, Chicago, IL, USA
• Sai-Hong Ignatius Ou, Orange, CA, USA
• Cecile Le Pechoux, Villejuif, France
• Natasha Leighl, Toronto, ON, Canada
• Tetsuya Mitsudomi, Osaka, Japan
• Jürgen Wolf, Cologne, Germany
• Yi-Long Wu, Guangzhou, China
• Alona Zer, Petah Tikva, Israel

Policy and preventive strategies

• Track Chair: Jean-Yves Blay, Lyon, France

• Paolo Giovanni Casali, Milan, Italy
• Christine Chomienne , Paris , France
• Michel Coleman, London, UK
• Suzette Delaloge, Villejuif, France
• Judith Balmana, Barcelona, Spain
• Denis Lacombe, Brussels , Belgium
• Ruth Ladenstein, Vienna, Austria
• Jose Maria Martin Moreno, Valencia, Spain
• Shiran Shapira, Tel Aviv, Israel
• Tanja Spanic, Ljubljana, Slovenia
• Dario Trapani, Milan, Italy
• Elisabete Weiderpass, Lyon, France

Sarcoma

• Track Chair: Bernd Kasper, Mannheim, Germany

• Sylvie Bonvalot, Paris , France
• Kjetil Boye, Oslo, Norway
• Tom Wei-Wu Chen, Taipei, Taiwan
• Robin Jones, London, UK
• Aisha Miah, London, UK
• Zsuzsanna Papai, Budapest, Hungary
• Cesar Serrano, Barcelona, Spain
• Silvia Stacchiotti, Milan, Italy
• Joanna Szkandera, Graz, Austria
• Winan Van Houdt, Amsterdam, Netherlands
• Eva Wardelmann, Muenster, Germany
• Breelyn Wilky , Aurora, CO, USA

Supportive and palliative care

• Track Chair: Matteo Lambertini, Genoa, Italy

• Cristiane Bergerot, Duarte, CA, USA
• David Hui, Houston, TX, USA
• Karin Jordan, Potsdam, Germany
• Anne Letsch, Kiel, Germany
• Maryam Lustberg, New Haven, CT, USA
• Mario Mandalà, Perugia, Italy
• Christina Ruhlmann, Odense, Denmark
• Mitsue Saito, Bunkyo-tu, Japan
• Ines Vaz-Luis, Villejuif, France
• Jayne Wood, London, UK
• Christine Wyns, Brussels, Belgium
• Camilla Zimmermann, Toronto, ON, Canada

For more updates on ESMO24, visit oncodaily.com